INFLUX HEALTHTECH LIMITED Share Price

₹ 255.20

-₹1.80 (-0.7%)

Last updated 26 Oct, 2026, 15:28 IST

NSE: INFLUX

INFLUX HEALTHTECH LIMITED Share Price Today

As of 27 Oct 2026, INFLUX HEALTHTECH LIMITED share price is ₹255.20. The stock opened at ₹259.00, compared to its previous close of ₹257.00. During today's trading session, INFLUX HEALTHTECH LIMITED share price moved in the range of ₹251.25 to ₹261.00, with an average price of ₹256.13 for the day. Looking at its last 52-week, the stock has touched a low of ₹168.50 and a high of ₹315.00. On the performance front, INFLUX HEALTHTECH LIMITED share price has increased by 1.04% over the last six months and is up 51.10% on a year-on-year basis.

₹251.25

0.70% down today

₹261.00

1D LOW

1D HIGH

INFLUX HEALTHTECH LIMITED Stock Insights

Stock Performance

OutperformingBeat Nifty by 8.47 % in last 6 month

Shareholding Pattern

DIIDII increased stake by 8278.93%

Shareholding Pattern

FIIFII decreased stake by 91.10%

Stock Performance

OutperformingBeat Nifty by 8.47 % in last 6 month

Shareholding Pattern

DIIDII increased stake by 8278.93%

Shareholding Pattern

FIIFII decreased stake by 91.10%

Volume

10,200

Average traded price

₹257.99

Last traded time

03:28:01 26 Oct

Last traded quantity

600

₹205.60₹308.40

Circuit Low

Circuit High

₹168.50₹315.00

52-Week Low

52-Week High

Circuit

₹205.60

₹308.40

52-week

₹168.50

₹315.00

Mkt Cap Cr

594.97

P/E

22.77

P/B

4.64

ROA

20.34%

ROE

20.39%

ROCE

27.15%

Quick Ratio

2.89

EV/EBITDA

14.18

Mkt Cap Cr

594.97

P/E

22.77

P/B

4.64

ROA

20.34%

ROE

20.39%

ROCE

27.15%

Quick Ratio

2.89

EV/EBITDA

14.18

Based on fundamentals, this stock's

Performance

Poor

Influx Health. has underperformed the market

Valuation

Fairly Valued

Influx Health. appears to be fairly valued compared to its peers

Peer Comparison

Peer comparison — key ratios
Name	Mkt Cap Cr	P/E	P/B	ROA	ROE	ROCE	Quick Ratio	EV/EBITDA
Sun Pharmaceutical Industries	4,18,204.09	34.51	5.0	11.19%	13.74%	17.33%	2.31	21.28
Divis Laboratories	2,38,496.97	81.54	14.23	14.6%	15.32%	19.56%	3.5	53.9
Torrent Pharmaceuticals	1,70,480.87	79.08	20.27	4.7%	11.42%	11.37%	0.75	33.12
Zydus Lifesciences	1,12,503.47	24.5	4.15	8.57%	18.59%	17.35%	0.91	15.01
Cipla	1,08,012.30	32.19	3.14	7.92%	11.27%	14.95%	2.5	18.34
Laurus Labs	1,06,657.63	97.82	20.12	10.38%	16.77%	16.14%	0.68	52.14
Dr. Reddy's Laboratories	1,02,206.60	32.11	2.68	4.79%	7.21%	8.58%	1.35	17.5
Mankind Pharma	91,572.10	44.29	5.62	7.36%	11.74%	13.13%	0.74	24.1
Aurobindo Pharma	90,294.05	24.33	2.38	6.34%	9.25%	11.76%	1.15	11.56
Lupin	88,028.32	15.86	3.92	14.47%	23.76%	24.88%	1.42	9.43

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

INFLUX HEALTHTECH LIMITED Company Background

ISIN

INE0MYZ01012

Sector Market Cap

₹ 594.97 Cr

Influx Healthtech Limited is an India-based healthcare product-focused company. The Company operates as a contract development and manufacturing organization. It specializes in a diverse range of products across several segments, including dietary/nutritional supplements, cosmetics, ayurvedic/herbal, veterinary feed supplements and homecare segments. This includes the production of active pharmaceutical ingredients and the manufacturing of finished dosage forms such as tablets, capsules, and injectables. It manufactures dietary and nutritional supplements in the form of tablets, capsules, powders, liquid orals, soft gels, lozenges, jellies, oral dispersible films, candies, gummies and effervescent tablets, and others. It manufactures cosmetics products for men and women, which include skincare and body care products, hair care and beard care solutions, and face masks and soaps. It manufactures ayurvedic formulations in the form of tablets, capsules, powder, liquid orals and others.

INFLUX HEALTHTECH LIMITED Financial Highlights

Revenue: INFLUX HEALTHTECH LIMITED reported revenue of ₹148.16 crore in FY26 vs ₹104.98 crore in FY25. It showed an increase of 41.13% on a yearly basis.
Operating Profit: INFLUX HEALTHTECH LIMITED reported an operating profit of ₹27.23 crore in FY26 vs ₹17.71 crore in FY25. It showed an increase of 53.75% on a year-on-year basis.
Net Profit: INFLUX HEALTHTECH LIMITED reported a net profit of ₹20.54 crore in FY26 vs ₹13.27 crore in FY25. It showed an increase of 54.79% on a yearly basis.

Know more

Promoters

73.53%

FII

0.16%

Other DII

5.65%

Retail and other

20.66%

Mutual funds

0.00%

Foreign Institutional Investor (FII)

FII shareholding by period
Feb 2025	0.00%
Jun 2025	3.38%
Sep 2025	1.83%
Mar 2026	0.16%

1 day

+0.10%

1 week

-2.09%

1 month

-8.60%

1 year

+51.10%

3 years

+103.84%

5 years

+103.84%

Day

Open / Close

Change %

26 Oct 26

₹259.00 / ₹255.20

-0.70%

23 Oct 26

₹260.80 / ₹257.00

-0.43%

22 Oct 26

₹255.00 / ₹258.10

-1.73%

21 Oct 26

₹256.00 / ₹262.65

+1.21%

INFLUX HEALTHTECH LIMITED Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
Particulars	Mar 2026
Revenue	₹146.83
Other Income	₹1.33
Total Revenue	₹148.17
Total Expenses	₹120.94
Profit Before Tax	₹27.23
Tax	₹6.69
Profit After Tax	₹20.54
EPS - Basic	₹9.35
EPS - Diluted	₹9.35

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
Particulars	Mar 2026
Profit before tax	₹27.23
Income before WC changes	₹30.36
Change in Assets	-₹8.10
Change in Liabilities	-₹10.03
Change in WC	-₹18.13
Cash flow from Operations	₹3.89
Cash flow from Investing	-₹25.16
Cash flow from Financing	₹44.53
Total Cash Flow	₹23.25
Cash (Start of the year)	₹1.91
Cash (End of the year)	₹25.17

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
Particulars	Mar 2026
Non-Current Assets	₹42.24
Current Assets	₹81.46
Total Assets	₹123.70
Current Liabilities	₹22.71
Net Current Asset	₹58.75
Non-Current Liabilities	₹0.23
Equity Capital	₹100.76
Total Equity & Liabilities	₹123.70

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Revenue	₹146.83	₹104.85	₹99.97	₹76.06
Other Income	₹1.33	₹0.13	₹0.05	₹0.00
Total Revenue	₹148.17	₹104.99	₹100.02	₹76.06
Total Expenses	₹120.93	₹87.27	₹85.08	₹66.32
Profit Before Tax	₹27.23	₹17.71	₹14.93	₹9.74
Tax	₹6.69	₹4.44	₹3.80	₹2.54
Profit After Tax	₹20.54	₹13.27	₹11.13	₹7.20
EPS - Basic	₹9.35	₹7.31	₹6.13	₹3.96
EPS - Diluted	₹9.35	₹7.31	₹6.13	₹3.96

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Profit before tax	₹27.23	₹17.71	₹14.93	₹9.74
Income before WC changes	₹30.37	₹20.69	₹17.21	₹10.74
Change in Assets	-₹8.10	-₹25.12	-₹5.79	-₹4.77
Change in Liabilities	-₹10.03	₹15.93	₹0.47	₹3.39
Change in WC	-₹18.13	-₹9.20	-₹5.32	-₹1.38
Cash flow from Operations	₹3.89	₹7.06	₹8.94	₹6.82
Cash flow from Investing	-₹25.17	-₹8.64	-₹8.36	-₹4.88
Cash flow from Financing	₹44.53	-₹0.11	-₹0.53	₹0.14
Total Cash Flow	₹23.25	-₹1.70	₹0.06	₹2.08
Cash (Start of the year)	₹1.91	₹3.61	₹3.55	₹1.47
Cash (End of the year)	₹25.16	₹1.91	₹3.61	₹3.55

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Non-Current Assets	₹42.25	₹21.28	₹15.42	₹8.24
Current Assets	₹81.45	₹49.02	₹25.68	₹20.06
Total Assets	₹123.70	₹70.30	₹41.10	₹28.30
Current Liabilities	₹22.71	₹33.92	₹17.98	₹16.39
Net Current Asset	₹58.74	₹15.10	₹7.70	₹3.67
Non-Current Liabilities	₹0.23	₹0.23	₹0.34	₹0.26
Equity Capital	₹100.76	₹36.15	₹22.78	₹11.65
Total Equity & Liabilities	₹123.70	₹70.30	₹41.10	₹28.30